Acorda Therapeutics: Rebuilding the Spinal Cord

Murray, Fiona and Kolesnik, Marina and Enriquez, Juan and West, Jonathan (2004) Acorda Therapeutics: Rebuilding the Spinal Cord. Other. Harvard Business School.

Full text not available from this repository.

Official URL: http://dx.doi.org/10.1225/604014

Abstract

Description: Acorda is an early-stage life science start-up with a promising product that is close to reaching the market (Phase III clinical trials). The company is grappling with how to expand its portfolio of molecules to make the business more sustainable. It faces classic in-licensing choices, including what disease indication, what stage of development, how many molecules, and on what terms. Learning Objective: To allow students to examine a portfolio of choices and their impact on the overall business rather than on a single licensing decision. Setting: New York, NY; United States; Biotechnology industry; start-up; 2003

Item Type:	Report (Other)
Subjects:	350000 Commerce, Management, Tourism and Services > 350300 Banking, Finance and Investment > 350301 Finance 350000 Commerce, Management, Tourism and Services > 350200 Business and Management > 350209 Small Business Management 350000 Commerce, Management, Tourism and Services > 350600 Services > 350699 Services not elsewhere classified 350000 Commerce, Management, Tourism and Services > 350200 Business and Management > 350211 Innovation and Technology Management 270000 Biological Sciences > 270800 Biotechnology
ID Code:	2734
Deposited By:	Miss Alexandra Lejda
Deposited On:	02 Jan 2008 17:03
Last Modified:	09 Jan 2008 02:30
ePrint Statistics:	View statistics for this ePrint

Repository Staff Only: item control page